The therapeutic effect of OPC transplantation on white matter injury in spinal cord disease has been attributed in part to secreted growth factors, such as BDNF (Zhang et al., 2006; Manley et al., 2017). The gene discussed is BDNF; the disease is spinal cord disorder.